Patent details
EP3315606 Title: ANTI-HUMAN TRANSFERRIN RECEPTOR ANTIBODY PERMEATING BLOOD-BRAIN BARRIER
Basic Information
- Publication number:
- EP3315606
- PCT Application Number:
- JP2016068738
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP168144640
- PCT Publication Number:
- WO2016208695
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- ANTI-HUMAN TRANSFERRIN RECEPTOR ANTIBODY PERMEATING BLOOD-BRAIN BARRIER
- French Title of Invention:
- ANTICORPS ANTI-RÉCEPTEUR DE TRANSFERRINE HUMAINE PASSANT AU TRAVERS DE LA BARRIÈRE HÉMATOENCÉPHALIQUE
- German Title of Invention:
- ANTIKÖRPER GEGEN MENSCHLICHEN TRANSFERRIN-REZEPTOR, DER BLUT-HIRN-SCHRANKE DURCHDRINGT
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 23/12/2025
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 02/02/2026
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 26/11/2025
- Unitary Effect Registration Date:
- 02/02/2026
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 24/06/2016
- Grant date:
- 26/11/2025
- EP Publication Date:
- 02/05/2018
- PCT Publication Date:
- 29/12/2016
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 26/11/2025
- EP B1 Publication Date:
- 26/11/2025
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 24/06/2036
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 19/11/2025
- Name:
- JCR Pharmaceuticals Co., Ltd.
- Address:
- 3-19 Kasuga-cho, Ashiya-shi Hyogo 659-0021, Japan (JP)
Inventor
1
- Name:
- SONODA, Hiroyuki
- Address:
- Japan (JP)
2
- Name:
- TAKAHASHI, Kenichi
- Address:
- Japan (JP)
Priority
- Priority Number:
- 2015144379
- Priority Date:
- 24/06/2015
- Priority Country:
- Japan (JP)
Classification
- IPC classification:
- C12N 15/09; A61K 39/395; A61K 45/00; A61P 9/10; A61P 21/02; A61P 21/04; A61P 25/00; A61P 25/14; A61P 25/16; A61P 25/18; A61P 25/24; A61P 25/28; A61P 31/04; A61P 31/12; A61P 35/00; C07K 14/475; C07K 16/18; C07K 16/28; C07K 16/46; C07K 19/00;
Publication
European Patent Bulletin
1
- Issue number:
- 202548
- Publication date:
- 26/11/2025
- Description:
- Grant (B1)
2
- Issue number:
- 202605
- Publication date:
- 28/01/2026
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202610
- Publication date:
- 04/03/2026
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|